Journal
PRION
Volume 5, Issue 3, Pages 123-125Publisher
LANDES BIOSCIENCE
DOI: 10.4161/pri.5.3.16327
Keywords
prion; (PrP)-Pr-Ctm; ER stress; transmembrane region; mutant
Categories
Funding
- Chinese National Natural Science Foundation [30800975]
- National Basic Research Program of China (973 Program) [2007CB310505]
- China Mega-Project for Infectious Disease [2009ZX10004-101, 2008ZX10004-008]
- SKLID [2008SKLID102, 2011SKLID204, 2011SKLID211]
Ask authors/readers for more resources
The pathogenic agent is hypothesized to be PrPSc in prion diseases. However, little accumulation of PrPSc is repeatedly observed in some kinds of natural and experimental prion diseases, including some special genetic human prion diseases. One of the specific topology forms of PrP, (PrP)-Pr-Ctm, representing a key neurotoxic intermediate in prion disorders, has been testified in cell-free translation systems and transgenic mice models. Recently, some studies have showed that point-mutations within the hydrophobic transmembrane region increase the amount of CtmPrP in cells, such as human homologue A117V which is associated with GSS and G114V associated with gCJD, while the mutations outsides transmembrane region do not. The retention of the CtmPrP in ER subsequently is able to induce ER stress and apoptosis, which is supported by upregulation of ER chaperone synthesis, such as Grp78, Grp58, Grp94, Bip and the transcription factor CHOP/GADD153. In conclusion, some kinds of intermediate forms of PrPSc, including CtmPrP, may work as the ultimate cause of neurodegeneration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available